chrX-132628521-T-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_001394073.1(HS6ST2):āc.1640A>Cā(p.His547Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000744 in 1,209,252 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00039 ( 0 hom., 11 hem., cov: 23)
Exomes š: 0.000043 ( 0 hom. 12 hem. )
Consequence
HS6ST2
NM_001394073.1 missense
NM_001394073.1 missense
Scores
2
5
10
Clinical Significance
Conservation
PhyloP100: 2.21
Genes affected
HS6ST2 (HGNC:19133): (heparan sulfate 6-O-sulfotransferase 2) Heparan sulfate proteoglycans are ubiquitous components of the cell surface, extracellular matrix, and basement membranes, and interact with various ligands to influence cell growth, differentiation, adhesion, and migration. This gene encodes a member of the heparan sulfate (HS) sulfotransferase gene family, which catalyze the transfer of sulfate to HS. Different family members and isoforms are thought to synthesize heparan sulfates with tissue-specific structures and functions. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.30805698).
BS2
High Hemizygotes in GnomAd4 at 11 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HS6ST2 | NM_001394073.1 | c.1640A>C | p.His547Pro | missense_variant | 5/5 | ENST00000370833.7 | NP_001381002.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HS6ST2 | ENST00000370833.7 | c.1640A>C | p.His547Pro | missense_variant | 5/5 | 5 | NM_001394073.1 | ENSP00000359870 |
Frequencies
GnomAD3 genomes AF: 0.000387 AC: 43AN: 111253Hom.: 0 Cov.: 23 AF XY: 0.000329 AC XY: 11AN XY: 33421
GnomAD3 genomes
AF:
AC:
43
AN:
111253
Hom.:
Cov.:
23
AF XY:
AC XY:
11
AN XY:
33421
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000830 AC: 15AN: 180785Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67115
GnomAD3 exomes
AF:
AC:
15
AN:
180785
Hom.:
AF XY:
AC XY:
1
AN XY:
67115
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000428 AC: 47AN: 1097999Hom.: 0 Cov.: 31 AF XY: 0.0000330 AC XY: 12AN XY: 363465
GnomAD4 exome
AF:
AC:
47
AN:
1097999
Hom.:
Cov.:
31
AF XY:
AC XY:
12
AN XY:
363465
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000387 AC: 43AN: 111253Hom.: 0 Cov.: 23 AF XY: 0.000329 AC XY: 11AN XY: 33421
GnomAD4 genome
AF:
AC:
43
AN:
111253
Hom.:
Cov.:
23
AF XY:
AC XY:
11
AN XY:
33421
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
12
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 13, 2021 | The c.1640A>C (p.H547P) alteration is located in exon 6 (coding exon 5) of the HS6ST2 gene. This alteration results from a A to C substitution at nucleotide position 1640, causing the histidine (H) at amino acid position 547 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.;.;T
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;T;T
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.;L
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;.;.
REVEL
Uncertain
Sift
Benign
D;D;.;.
Sift4G
Benign
T;T;T;T
Polyphen
D;.;.;D
Vest4
MVP
MPC
2.0
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at